A Seattle-based biotech company is turning heads on Wednesday morning after it was announced that the company received a US patent for its respiratory tract delivery of levodopa...

To read the full story on AllPennyStocks.com, click here.

Impel Pharmaceuticals (NASDAQ:IMPL)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Impel Pharmaceuticals Charts.
Impel Pharmaceuticals (NASDAQ:IMPL)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Impel Pharmaceuticals Charts.